{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T05:39:18Z","timestamp":1781501958773,"version":"3.54.1"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Mayo Clinic Department of Neurology Research Fund"},{"DOI":"10.13039\/100005337","name":"American Academy of Child & Adolescent Psychiatry","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005337","id-type":"DOI","asserted-by":"crossref"}]},{"name":"UCB"},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"FDA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001605","name":"Epilepsy Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001605","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001454","name":"American Epilepsy Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001454","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Neuren Pharmaceuticals"},{"DOI":"10.13039\/501100003769","name":"Eisai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.eplepsyres.2014.12.007","type":"journal-article","created":{"date-parts":[[2014,12,15]],"date-time":"2014-12-15T13:21:14Z","timestamp":1418649674000},"page":"115-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["The effects of lacosamide on depression and anxiety in patients with epilepsy"],"prefix":"10.1016","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8573-7340","authenticated-orcid":false,"given":"Brian D.","family":"Moseley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devlin","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ogonna","family":"Iwuora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey R.","family":"Strawn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Privitera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2014.12.007_bib0005","first-page":"112","article-title":"Depression and anxiety in patients with epilepsy, with or without other chronic disorders","volume":"13","author":"Asadi-Pooya","year":"2011","journal-title":"Iran. Red Crescent Med. J."},{"key":"10.1016\/j.eplepsyres.2014.12.007_bib0010","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/j.1528-1167.2007.01188.x","article-title":"Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures","volume":"48","author":"Ben-Menachem","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2014.12.007_bib0015","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.yebeh.2013.08.004","article-title":"Efficacy and safety of pregabalin in refractory focal epilepsy with and without comorbid anxiety disorders \u2013 results of an open-label, parallel group, investigator-initiated, proof-of-concept study","volume":"29","author":"Brandt","year":"2013","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2014.12.007_bib0020","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/JCP.0b013e318253a186","article-title":"Behavioral adverse effects of antiepileptic drugs in epilepsy","volume":"32","author":"Eddy","year":"2012","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.eplepsyres.2014.12.007_bib0025","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S1474-4422(06)70415-X","article-title":"Rapid detection of major depression in epilepsy: a multicentre study","volume":"5","author":"Gilliam","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.eplepsyres.2014.12.007_bib0030","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0920-1211(92)90090-G","article-title":"Interictal depression in epilepsy","volume":"12","author":"Indaco","year":"1992","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2014.12.007_bib0035","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1528-1157.1996.tb00006.x","article-title":"The clinical course of epilepsy and its psychosocial correlates: findings from a U.K. Community study","volume":"37","author":"Jacoby","year":"1996","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2014.12.007_bib0040","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2147\/NDT.S7967","article-title":"Lacosamide for the prevention of partial onset seizures in epileptic adults","volume":"6","author":"Kelemen","year":"2010","journal-title":"J. Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.eplepsyres.2014.12.007_bib0045","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2165\/11599780-000000000-00000","article-title":"Beneficial and adverse psychotropic effects of antiepileptic drugs in patients with epilepsy: a summary of prevalence, underlying mechanisms and data limitations","volume":"26","author":"Piedad","year":"2012","journal-title":"CNS Drugs"},{"key":"10.1016\/j.eplepsyres.2014.12.007_bib0050","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.yebeh.2006.06.019","article-title":"Death from suicide versus mortality from epilepsy in the epilepsies: a meta-analysis","volume":"9","author":"Pompili","year":"2006","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2014.12.007_bib0055","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1528-1157.1994.tb02510.x","article-title":"Depressive symptomatology in a general hospital sample of outpatients with temporal lobe epilepsy: a controlled study","volume":"35","author":"Robertson","year":"1994","journal-title":"Epilepsia"},{"issue":"Suppl. 1","key":"10.1016\/j.eplepsyres.2014.12.007_bib0060","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/epi.12504","article-title":"Adverse effects and safety profile of perampanel: a review of pooled data","volume":"55","author":"Rugg-Gunn","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2014.12.007_bib0065","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.eplepsyres.2014.12.007_bib0070","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1111\/epi.12681","article-title":"Conversion to lacosamide monotherapy in the treatment of focal epilepsy: results from a historical-controlled, multicenter, double-blind study","volume":"55","author":"Wechsler","year":"2014","journal-title":"Epilepsia"}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121114003660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121114003660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:32:59Z","timestamp":1760275979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121114003660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":14,"alternative-id":["S0920121114003660"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2014.12.007","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of lacosamide on depression and anxiety in patients with epilepsy","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2014.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}